McKesson Appoints Tom Rodgers to Executive Vice President & Chief of Strategy and Business Development Officer

McKesson Corporation announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer, effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team. Rodgers succeeds Bansi Nagji, who stepped down from the role on March 31, 2020.

As executive vice president and chief strategy and business development officer, Rodgers will have responsibility for the company’s overall strategic plan and initiatives. He will also be responsible for key acquisitions and internal programs that drive financial performance, enhance innovation, and deliver added value for our customers.

Rodgers currently serves as senior vice president and managing director for McKesson Ventures. Rodgers has more than 25 years of experience working in emerging companies, large healthcare environments, and venture capital firms. Before he worked for McKesson Ventures, Rodgers served as director of strategic investments for Cambia Health and was a partner at Advanced Technology Ventures, where he led the fund’s investments in healthcare technology. He holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania.

“McKesson has a long history of evolving our company in meaningful ways that enable us to lead in a rapidly changing healthcare environment,” said McKesson Corporation CEO Brian Tyler. “Tom’s experience in both venture capital and large healthcare environments will be extremely valuable to our leadership team as we continue to strengthen our core business and transform our company to create new opportunities to deliver future growth.”

At McKesson Ventures, Dave Schulte has been named Rodgers’ successor. Dave joined McKesson in 2015 and most recently served as a managing director for McKesson Ventures. He has more than 20 years of experience as an investor and investment banker, partnering with entrepreneurs to build innovative healthcare and technology businesses. Before he joined McKesson, Schulte ran Kaiser Permanente Ventures, where he helped to build the investment program from $20 million to $400 million of assets under management. He is a graduate of St. John’s University and earned a Master of Public Policy degree from Harvard.

Read the original press release here.